PDI

PDI
Share

At PDI, we never forget who we are all working for. That’s why we offer a broad range of evidence-based, market leading Interventional Care, Environment of Care, and Patient Care solutions, all designed to help reduce preventable infections, control healthcare costs, and ultimately help save lives. It’s all part of our passion to Be The Difference®, every day.

PDI

 •  October 17, 2017

Author: Neal Lorenzi with Expert Commentary from Elise Tordella, VP of Marketing at PDI Source: Healthcare Facilities Management "The latest cleaning chemicals for hospitals are formulated to not only clean and disinfect, but to counteract health care-associated infection (HAI)-causing pathogens and other emerging threats. They also are formulated...

PDI

 •  October 16, 2017

Authors: Chris Snively, PhD, Sr. Scientist, Compatibility, PDI, and Edward Kung, PhD, Sr. Manager, Healthcare Technology & Innovation, SABIC Source: Surgical Products Magazine "Thorough and effective surface disinfection is top-of-mind in any infection prevention program, but there is one crucial element that can be challenging to implement in...

PDI

 •  June 7, 2017

What You'll Find We are evolving rapidly to do more and offer more in the fight against preventable infections. Check this page to stay informed about important PDI news and events.

PDI

 •  April 18, 2017

Prevantics® brand has them both covered.
Skin: Antiseptic Swabstick and Maxi Swabstick’s 7 day continued antimicrobial activity correlates well with many dressing change protocols.
Site: Device Swab’s 5 second scrub- 5 second dry time improves compliance.
Request your FREE sample kit at www.pdihc.com/SkinPlusSite
Attending INS? Visit our booth...

PDI

 •  March 30, 2017

In February, the World Health Organization (WHO) published their first list of antibiotic-resistant “priority pathogens”. This is a list of the most concerning bacteria that pose the “greatest threat to human health”. This list is divided into three levels of antibiotic-resistant bacteria based on their significance and potential impact to global...

PDI

 •  March 21, 2017

Author: Leanne Taylor with Expert Commentary from Cheryl Moran, Senior Director of Portfolio Management at PDI Source: British Plastics & Rubber "SABIC and PDI evaluated how well SABIC’s thermoplastics withstand repeated exposure to a surface disinfectant product to help prevent healthcare-associated infections (HAIs)." Read full article...

PDI

 •  January 30, 2017

Source: Infection Control Today "PDI, a leader in infection prevention products and solutions, announces an exclusive relationship with two of the world’s leading experts in infection prevention and epidemiology, Bill Rutala, PhD, MPH, CIC and David Weber, MD, MPH. Rutala and Weber will support the company’s mission to advance solutions that help...

PDI

 •  January 24, 2017

Dr. Rutala and Dr. Weber join as exclusive consultants to help shape disinfection, antisepsis and hand hygiene efforts Orangeburg, NY – January 17, 2017 – PDI, a leader in infection prevention products and solutions, announces an exclusive relationship with two of the world’s leading experts in infection prevention and epidemiology, Bill Rutala,...

PDI

 •  January 10, 2017

Orangeburg, NY – January 10, 2017 – PDI, a leader in infection prevention products and solutions, announces the appointment of Brent Boucher to a newly created role, Executive in Residence, for the Infection Prevention Business Unit. As Executive in Residence, Brent will lead key projects and initiatives critical to the company’s growth and...

PDI

 •  January 4, 2017

Chlorhexidine Gluconate for the Prevention of Central Line-Associated Bloodstream Infections - Current Science Chlorhexidine gluconate (CHG) is an antibacterial antiseptic with the ability to inhibit and kill bacteria associated with healthcare-associated infections (HAIs). In the last two decades, investigators have researched the use of CHG for...